Skip to main content
Figure 1 | Orphanet Journal of Rare Diseases

Figure 1

From: Consequences of a global enzyme shortage of agalsidase beta in adult Dutch Fabry patients

Figure 1

Course of preparations and dosages during agalsidase beta shortage. The numbers in the bars represent the number of patients in different dosage and preparation groups being the continued agalsidase beta group, the direct and later switch to agalsidase alpha group. The occurrence of clinical events during agalsidase dose reduction or during switch to agalsidase alpha is outlined on a schematic timeline below the figure. Abbreviations: CE: clinical events.'

Back to article page